Clinical trial Recruiting at 1 site Interventional Ages 45 to 65

Gluteus medius and quadratus lumborum strengthening for pelvic alignment, balance, and mobility after subacute stroke

Official title: Effects of Contralateral Gravity Eliminated Gluteus Medius and Ipsilateral Quadratus Lumborum Strengthening on Pelvic Alignment, Balance and Functional Mobility on Subacute Stroke Patients

Run by Lahore University of Biological and Applied Sciences · NCT07902310 · Data updated 2026-11-12

This trial tests two strengthening approaches added to standard physical therapy to see which best improves pelvic alignment, balance, and mobility in people 1–6 months after a first stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages45 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorLahore University of Biological and Applied Sciences
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedDecember 30, 2026
Study endsJanuary 30, 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07902310 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45–65 with a first-ever subacute stroke (1–6 months) able to stand with minimal assistance and with Brunnstrom III–V and BBS < 45.

Probably not a fit

Patients outside the Brunnstrom III–V range, with recurrent stroke, severe cognitive impairment, or inability to stand may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind trial compares contralateral gravity-eliminated gluteus medius strengthening with ipsilateral quadratus lumborum strengthening, each plus conventional physiotherapy, in adults with subacute stroke. Forty participants aged 45–60 years will be recruited at Alfalah Medical Center in Lahore and randomized 1:1 to the two intervention arms, three times per week for six weeks. Outcomes focus on pelvic alignment, balance, and functional mobility, with assessments conducted by blinded evaluators. Eligibility includes a first-ever stroke 1–6 months prior, Brunnstrom III–V, ability to follow commands, and a Berg Balance Scale score below 45; several exclusion criteria ensure medical stability and safety during training.

Why it matters

Potential benefit: If successful, the targeted strengthening could improve balance and mobility, potentially reducing fall risk for subacute stroke patients.

How similar studies have gone: Previous research supports targeted strengthening for balance in stroke, but this exact contralateral gravity-eliminated versus ipsilateral strengthening comparison is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients aged 45-65 years. Patients with a first-ever stroke occurring 1-6 months before enrollment (subacute stroke).

Patients classified within Brunnstrom Recovery Stages III-V. Medically stable patients who are able to follow simple verbal commands. Patients able to stand independently or with minimal assistance. Patients with a Berg Balance Scale (BBS) score below 45 out of 56.

Exclusion Criteria:

Patients with a history of recurrent stroke. Patients with severe cognitive impairment. Patients with other neurological disorders that may affect rehabilitation outcomes.

Patients with severe lower-limb musculoskeletal conditions. Patients with severe spasticity, defined as a Modified Ashworth Scale (MAS) score greater than 3, according to the study protocol.

Patients with uncontrolled cardiovascular or respiratory disease. Patients with severe visual or vestibular impairment affecting balance. Patients unable to stand even with assistance. Patients participating in another rehabilitation research study during the study period.

\-

Where it's running

  • Alfalah Medical Center
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.